Page last updated: 2024-08-26

sr141716 and Ascites

sr141716 has been researched along with Ascites in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernardi, M; Caraceni, P; Croci, T; Domenicali, M; Giannone, F; Pertosa, AM; Principe, A; Trevisani, F; Zambruni, A1
Bifulco, M; D'Alessandro, A; Galgani, M; Gazzerro, P; Laezza, C; Malfitano, AM; Matarese, G1

Other Studies

2 other study(ies) available for sr141716 and Ascites

ArticleYear
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis.
    Gastroenterology, 2009, Volume: 137, Issue:1

    Topics: Animals; Ascites; Blood Pressure; Carbon Tetrachloride; Cardiac Output; Diuresis; Dose-Response Relationship, Drug; Kidney; Liver Cirrhosis, Experimental; Male; Natriuresis; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Renal Circulation; Rimonabant; Sodium; Sodium, Dietary; Time Factors; Vascular Resistance

2009
The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice.
    Pharmacological research, 2012, Volume: 65, Issue:3

    Topics: Animals; Antineoplastic Agents; Apoptosis; Ascites; Cell Cycle; Cell Line, Tumor; Cell Survival; Female; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Sarcoma

2012